Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity (Q68091001)
Jump to navigation
Jump to search
scientific article published on 01 March 1988
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity |
scientific article published on 01 March 1988 |
Statements
Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity (English)
Kawase I
Komuta K
Hara H
Inoue T
Hosoe S
Ikeda T
Shirasaka T
Yokota S
Tanio Y